section name header

Basics ⬇

DESCRIPTION

Hurler syndrome is the most severe phenotype within a spectrum of lysosomal storage disorders known as mucopolysaccharidosis I due to deficiency of the enzyme #x03B1-L-iduronidase. Current terminology applies the term severe MPSI for what has been known as Hurler syndrome and attenuated MPS I for Hurler-Scheie and Scheie syndromes.

EPIDEMIOLOGY

Incidence

Incidence is ~1/100,000 live births. The majority MPS I are the severe form (50–80%), although that may be related to a higher rate of diagnosis in the severe form vs. attenuated forms.

RISK FACTORS

Genetics

Autosomal recessive, caused by 1 of 110 known mutations in IDUA gene, localized on chromosome 4p16.3. The specific mutation is believed to determine phenotype.

PATHOPHYSIOLOGY

ETIOLOGY

Genetic; caused by a deficiency of the lysosomal enzyme #x03B1-l-iduronidase

Diagnosis ⬆ ⬇

History

Physical Exam

DIAGNOSTIC TESTS & INTERPRETATION

Lab

Imaging

DIFFERENTIAL DIAGNOSIS

Medication (Drugs) ⬆ ⬇

Treatment ⬆ ⬇

SURGERY

Some case reports of aortic and mitral valve surgery

Ongoing Care ⬆ ⬇

FOLLOW-UP RECOMMENDATIONS

Patient Monitoring

Annual cardiac evaluations using echo recommended to assess for valvular disease, heart failure, cor pulmonale, and cardiomyopathy

DIET

No restrictions

PATIENT EDUCATION

Activity: Limited

PROGNOSIS

Most patients with the severe MPS I phenotype (Hurlers) die before age 10 yr, usually of respiratory complications. Myocardial involvement has been demonstrated to regress with treatment (HSCT or ERT).

COMPLICATIONS

Respiratory failure, CHF

Miscellaneous ⬆ ⬇

CODES

ICD9

SNOMED

Reference(s) ⬆ ⬇

ADDITIONAL READING

SEE ALSO

Author(s) ⬆

Linda A. Pape